Bird & Bird LLP

The 'responsive and knowledgeable' team at Bird & Bird LLP has 'a strong understanding of the market', ensuring that it is a popular choice among investors and investees seeking and receiving funding throughout all stages of the investment life cycle, from "idea to exit". As well as the team's core venture capital expertise, both in London and across many of its international offices, clients also benefit from access to concomitant tech and life sciences-related IP and commercial expertise, of particular value to start-ups, in particular, as they scale up. 'Commercially astute' team head Struan Penwarden is 'very well-versed in the venture market', including in relation to venture debt matters, and is 'able to deal with all the various nuances that come up along the way'. James Baillieu is pivotal to the firm's success for investors (including corporate venturers) and companies within the biotech and healthcare sector, drawing upon a broad skill-set that includes financing, M&A, commercial and IPO expertise. The 'brilliant' Mark Rundall is 'very knowledgeable and commercially astute', traits with which he imparts to good effect for investors and high growth companies in the tech and energy sectors, in particular. The 'extremely dedicated' Adam Meisels, who was recently promoted to partner,  excels in cross-border transactions, particularly on matters with an Israeli nexus, where he has particular skill having previously worked in the country.